Evidence map›Paper›PMID 34824276›Full record

ArticleNature communications2021

AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway.

Hoi Yin Mak, Qian Ouyang, Sergey Tumanov, Jiesi Xu, Ping Rong, Feitong Dong, Sin Man Lam, Xiaowei Wang, Ivan Lukmantara, Ximing Du and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Role of theInternational journal of molecular sciences · 2025
    Review
  10. Effects ofInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alpha-Linolenic Acid Ameliorates Cognitive Impairment and Liver Damage Caused by Obesity.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Hoi Yin Mak *School of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, NSW, 2052, Australia.ORCID http://orcid.org/0000-0003-4242-2175
Qian Ouyang *MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, 210061, Nanjing, China.
Sergey Tumanov *Heart Research Institute, The University of Sydney, Newtown, NSW, 2042, Australia.
Jiesi XuState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China.
Ping RongMOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, 210061, Nanjing, China.
Feitong DongDepartment of Biology, Southern University of Science and Technology, 518055, Shenzhen, Guangdong, China.
Sin Man LamState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China.ORCID http://orcid.org/0000-0001-9037-904X
Xiaowei WangLaboratory of Lipid Metabolism, Hebei Medical University, 050017, Shijiazhuang, Hebei, China.
Ivan LukmantaraSchool of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, NSW, 2052, Australia.
Ximing DuSchool of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, NSW, 2052, Australia.ORCID http://orcid.org/0000-0002-6648-017X
Mingming GaoLaboratory of Lipid Metabolism, Hebei Medical University, 050017, Shijiazhuang, Hebei, China.
Andrew J BrownSchool of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, NSW, 2052, Australia.
Xin GongDepartment of Biology, Southern University of Science and Technology, 518055, Shenzhen, Guangdong, China.ORCID http://orcid.org/0000-0003-3469-7718
Guanghou ShuiState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China.ORCID http://orcid.org/0000-0002-1621-9643
Roland StockerHeart Research Institute, The University of Sydney, Newtown, NSW, 2042, Australia.ORCID http://orcid.org/0000-0002-7414-6681
Xun HuangState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China.ORCID http://orcid.org/0000-0002-2653-8293
Shuai ChenMOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, 210061, Nanjing, China.ORCID http://orcid.org/0000-0002-8511-911X
Hongyuan YangSchool of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, NSW, 2052, Australia. h.rob.yang@unsw.edu.au.ORCID http://orcid.org/0000-0002-8482-6031
UNSW Sydney · AUChinese Academy of Sciences · CNModel Animal Research Center · CNHebei Medical University · CNSouthern University of Science and Technology · CNThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AGPATs (1-acylglycerol-3-phosphate O-acyltransferases) catalyze the acylation of lysophosphatidic acid to form phosphatidic acid (PA), a key step in the glycerol-3-phosphate pathway for the synthesis of phospholipids and triacylglycerols. AGPAT2 is the only AGPAT isoform whose loss-of-function mutations cause a severe form of human congenital generalized lipodystrophy. Paradoxically, AGPAT2 deficiency is known to dramatically increase the level of its product, PA. Here, we find that AGPAT2 deficiency impairs the biogenesis and growth of lipid droplets. We show that AGPAT2 deficiency compromises the stability of CDP-diacylglycerol (DAG) synthases (CDSs) and decreases CDS activity in both cell lines and mouse liver. Moreover, AGPAT2 and CDS1/2 can directly interact and form functional complexes, which promote the metabolism of PA along the CDP-DAG pathway of phospholipid synthesis. Our results provide key insights into the regulation of metabolic flux during lipid synthesis and suggest substrate channelling at a major branch point of the glycerol-3-phosphate pathway.

Indexed as

AcyltransferasesAnimalsBiosynthetic PathwaysCell LineCytidine Diphosphate DiglyceridesDiacylglycerol CholinephosphotransferaseFatty AcidsHumansLipid DropletsLipogenesisLiverMiceMultienzyme ComplexesOleic AcidPhosphatidic Acids2-acylglycerophosphate acyltransferaseAcyltransferasesCytidine Diphosphate DiglyceridesDiacylglycerol CholinephosphotransferaseFatty AcidsMultienzyme ComplexesOleic AcidPhosphatidic Acids

Identifiers

PMID34824276
PMCPMC8616899
OpenAlexW3217424869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.